TrianglePUBLICATIONS · 22614970
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2012 Jul 1
- First author
- George S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- George S
- type
- Author
- name
- Wang Q
- type
- Author
- name
- Heinrich MC
- type
- Author
- name
- Corless CL
- type
- Author
- name
- Zhu M
- type
- Author
- name
- Butrynski JE
- type
- Author
- name
- Morgan JA
- type
- Author
- name
- Wagner AJ
- type
- Author
- name
- Choy E
- type
- Author
- name
- Tap WD
- type
- Author
- name
- Yap JT
- type
- Author
- name
- Van den Abbeele AD
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- George S
- type
- Author
- name
- Wang Q
- type
- Author
- name
- Heinrich MC
- type
- Author
- name
- Corless CL
- type
- Author
- name
- Zhu M
- type
- Author
- name
- Butrynski JE
- type
- Author
- name
- Morgan JA
- type
- Author
- name
- Wagner AJ
- type
- Author
- name
- Choy E
- type
- Author
- name
- Tap WD
- type
- Author
- name
- Yap JT
- type
- Author
- name
- Van den Abbeele AD
- type
- Author
- bibliography ids
- nci-bib-3fb549b6012233601c450896
- book metadata
- content sha256
- 2277030a7461c9a1bcc742bd3f36ae7fb6b6887f6d838fd1786c0d97045b41a0
- document type
- citation
- dois
- 10.1200/JCO.2011.39.9394
- electronic publication date
- display
- 2012 May 21
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22614970
- immutable id
- pubmed:22614970@2277030a7461c9a1bcc742bd3f36ae7fb6b6887f6d838fd1786c0d97045b41a0
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 19
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2401-7
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22614970
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 9121f166f2bf7b95afbf86d82edde5c0268c82c815b98d037f79b2bf638fb1af
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 Jul 1
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.
Preserved source evidence · Not medical advice